|
Volumn 315, Issue 14, 2016, Pages 1449-1450
|
Lifetime perspectives on primary prevention of atherosclerotic cardiovascular disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
CARDIOVASCULAR MORTALITY;
CARDIOVASCULAR RISK;
CHOLESTEROL BLOOD LEVEL;
CORONARY ARTERY ATHEROSCLEROSIS;
DECISION SUPPORT SYSTEM;
ELECTRONIC MEDICAL RECORD;
HIGH RISK PATIENT;
HUMAN;
LIFESPAN;
NOTE;
PRACTICE GUIDELINE;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
SYSTOLIC BLOOD PRESSURE;
ADULT;
ATHEROSCLEROSIS;
BLOOD;
CARDIOVASCULAR DISEASE;
COMPLICATION;
MIDDLE AGED;
RISK ASSESSMENT;
RISK FACTOR;
TIME FACTOR;
ADULT;
ATHEROSCLEROSIS;
CARDIOVASCULAR DISEASES;
CHOLESTEROL, LDL;
HUMANS;
MIDDLE AGED;
PRACTICE GUIDELINES AS TOPIC;
PRIMARY PREVENTION;
RISK ASSESSMENT;
RISK FACTORS;
TIME FACTORS;
|
EID: 84963811345
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2016.1654 Document Type: Note |
Times cited : (27)
|
References (7)
|